CSIMarket

Merger and Acquisition

Complete Solar Secures $40.5M to Power Its Acquisition of SunPower Assets,

September 9, 2024

Complete Solar Raises $40.5 Million for SunPower Asset Acquisition
In a strategic move aimed at expanding its foothold in the solar energy sector, Complete Solar has successfully raised $40.5 million through a convertible debenture. This financial maneuver is intended to bolster its ongoing bid for certain asset...

Management Announcement

Replimune Group Inc Gains FDA Alignment for RP1 Accelerated Approval Pathway, Inspiring 11.54% Share Price Surge in Q3 2024,

September 9, 2024

Replimune Announces Positive Pre-BLA Meeting with FDA and Confirms BLA Submission On Track for 2H 2024
- Alignment with FDA on accelerated approval pathway for RP1 in anti-PD1 failed melanoma
- Share price increases by 11.54% in Q3 of 2024
- Cumulative net loss of $-220 million with a negative return on ...

Merger and Acquisition

SMC Entertainment Aims to Diversify Portfolio with Letter of Intent to Acquire Bateau Asset Management

September 9, 2024


Breaking News
SMC Entertainment Enters Letter of Intent to Acquire Boutique Investment Manager, Bateau Asset Management

In a strategic move aimed at enhancing its investment capabilities, SMC Entertainment Inc. a leader in cloud computing and data analytics, has announced that it has entered into ...

Management Announcement

WatchDawg Unleashed: Innovating Veteran Suicide Reduction with Revolutionary Wearable Technology,

September 9, 2024

Halberd Corp. Introduces WatchDawg: A Promising Solution for Veteran Suicide Reduction
In recent years, the rising rates of veteran suicides have become a pressing concern that demands immediate attention. The tragic loss of life among those who have selflessly served their countries has propelled Halberd Corp. ...

Management Announcement

T2 Biosystems Pioneers New Direct-from-Blood Diagnostics and Implements Strategic Stock Split to Fuel Growth and Shareholder Value,

September 9, 2024

T2 Biosystems Accelerates Development of New Diagnostic Products and Implements Stock Split Strategy to Benefit Shareholders
T2 Biosystems Inc. a pioneering company specializing in innovative diagnostic tools, has recently provided updates on its new product development pipeline progress. The company has announc...

Our most Popular Articles
Business Update

Globalstar Expands Capabilities with Opening of New Satellite Operations Control Center in Covington, Louisiana

March 18, 2025

Globalstar Emerges as a Strategic Leader in Next-Gen Satellite Operations Despite Market Fluctuations Globalstar Expands Capabilities with New Operations Center Globalstar, Inc. (NASDAQ: GSAT), a pioneering name in next-generation telecommunications and technology, has taken a significant stride towards strengtheni...

Product Service News

Battle Born Launches Smart Lithium Batteries with Exclusive Black Friday Discounts, Shaping the Future of Energy St...

November 27, 2024

RENO, Nev. Nov. 25, 2024 Dragonfly Energy Holdings Corp (Nasdaq: DFLI), a recognized leader in energy storage and battery technology, is excited to announce the launch of its latest innovation the new Battle Born smart lithium batteries. This release marks a significant step forward in the evolution of battery ...

Management Changes

“Navigating Financial Headwinds: Village Farms International’s Bold Strategy Amid Regulatory Uncertainty”

April 1, 2025

Village Farms International Inc. (VFF), a notable entity in the cannabis and fresh produce sectors, is charting a complex course through financial challenges and regulatory hurdles as it positions itself for long-term growth. The appointment of Yvonne Trupiano as the Global Chief Human Resources Officer serves as a ...

Company News
Management Announcement

Replimune Group Inc Gains FDA Alignment for RP1 Accelerated Approval Pathway, Inspiring 11.54% Share Price Surge in Q3 2024,

September 9, 2024

Replimune Announces Positive Pre-BLA Meeting with FDA and Confirms BLA Submission On Track for 2H 2024
- Alignment with FDA on accelerated approval pathway for RP1 in anti-PD1 failed melanoma
- Share price increases by 11.54% in Q3 of 2024
- Cumulative net loss of $-220 million with a negative return on ...

Merger and Acquisition

SMC Entertainment Aims to Diversify Portfolio with Letter of Intent to Acquire Bateau Asset Management

September 9, 2024


Breaking News
SMC Entertainment Enters Letter of Intent to Acquire Boutique Investment Manager, Bateau Asset Management

In a strategic move aimed at enhancing its investment capabilities, SMC Entertainment Inc. a leader in cloud computing and data analytics, has announced that it has entered into ...

Management Changes

Navigating the Cosmos of Finance: Intuitive Machines Reworks Leadership Amidst Financial Challenges,

September 9, 2024



In a recent press release, Intuitive Machines, Inc. (Nasdaq: LUNR, LUNRW), a prominent space exploration, infrastructure, and services company, unveiled significant leadership appointments set to take effect on September 16, 2024. These developments include the transition of Pete McGrath from Senior Vice P...

Company News
Clinical Study

Advancing Psychedelic Medicine Initiation of Phase IIb Clinical Trial of Psilocybin for Adjustment Disorder in ...

September 9, 2024
Company News
Merger and Acquisition

Progress Expands Enterprise Software Portfolio with AI-Powered, Document-Centric Collaboration Platform

September 9, 2024
Company News
Clinical Study

Terns Pharmaceuticals Advancements in Obesity and Oncology Therapeutics with Promising Phase 1 Clinical Results

September 9, 2024
More Company News
Contract

Telesat Partners with Calian for Element Management System Development as Shares Outperform Market

September 9, 2024
Clinical Study

Breaking New Ground in Pediatric Autoimmune Therapy Cartesian Therapeutics’ Descartes-08 Garners FDA Rar...

September 9, 2024
Clinical Study

Harnessing Synthetic Biology The Promise of TNX-801 Amidst Financial Challenges for Tonix Pharmaceuticals

September 9, 2024
Clinical Study

for this Acrivon Therapeutics Unveils Robust Clinical Success and Innovative Pipeline at Upcoming Investor Even...

September 9, 2024
Clinical Study

Pivotal Advance in Graves Disease Therapy Immunovants Promising Developments and Challenges in Autoimmune Treatment...

September 9, 2024
Clinical Study

Azenosertib Pioneering Synergistic Strategies in Cancer Therapy Through Antibody Drug Conjugates

September 9, 2024
Clinical Study

Evaxion Biotech Achieves Milestones with mRNA Gonorrhea Vaccine EVX-B2 and Personalized Cancer Vaccine EVX-01,

September 9, 2024
Announcement

Master of Modern Logistics Malcolm Wilson to Grace Morgan Stanleys Laguna Conference,

September 9, 2024
Announcement

Unlocking Potential MoonLake Immunotherapeutics Poised for Growth Through Regulatory Milestones and Capital Markets U...

September 9, 2024
Merger and Acquisition

Synergy in Motion: Freedom Holdings and TAG Forge New Paths with Reverse Merger,

September 9, 2024
Related News
Clinical Study

Promising Interim Data on RLY-2608 A Breakthrough in Progression-Free Survival by Relay Therapeutics

Financing Agreement

Parsons Corporationns Strategic Advance in the Indo-Pacific through $68.5 Million Army Contractnn

Stocks
Merger and Acquisition

Realpha Tech Corp Strengthens Position in Real Estate Technology with Strategic Acquisition

Announcement

An Epoch of Progress Ellomay Capital Achieves Significant Progress in Solar Project Financing in Italy

Contract

Radware and Cirion Technologies A Partnership on the Rise Amidst Market Fluctuations

Business News
Management Announcement

WatchDawg Unleashed: Innovating Veteran Suicide Reduction with Revolutionary Wearable Technology,

Halberd Corp. Introduces WatchDawg: A Promising Solution for Veteran Suicide Reduction
In recent years, the rising rates of veteran suicides have become a pressing concern that demands immediate attention. The tragic loss of life among those who have selflessly served their countries has propelled Halberd Corp. ...

Management Announcement

T2 Biosystems Pioneers New Direct-from-Blood Diagnostics and Implements Strategic Stock Split to Fuel Growth and Shareholder Value,

T2 Biosystems Accelerates Development of New Diagnostic Products and Implements Stock Split Strategy to Benefit Shareholders
T2 Biosystems Inc. a pioneering company specializing in innovative diagnostic tools, has recently provided updates on its new product development pipeline progress. The company has announc...

Financing Agreement

Star Bulk Carriers Bolsters Position with Vessel Sale and Share Repurchase Strategynn,

nnStar Bulk Carriers Announces Significant Vessel Sale and Strategic Share Repurchase Amid Mixed Financial Performancenn
In a notable move, Star Bulk Carriers Corp. (Nasdaq: SBLK), a prominent player in the global shipping industry, has announced the sale of its oldest Capesize vessel, the m/v Star Triumph, whic...

Management Announcement

Scorpius Holdings Inc*s Ambitious Partnership Amidst Financial Turmoil: A Journey Towards Redemption,



Scorpius Holdings Inc, a leading player in the healthcare sector, has been selected to join the Rapid Response Partnership Vehicle (RRPV) in collaboration with the Biomedical Advanced Research and Development Authority (BARDA). This partnership aims to expedite the development of critical solutions for pub...

Merger and Acquisition

Complete Solar Secures $40.5M to Power Its Acquisition of SunPower Assets,

Complete Solar Raises $40.5 Million for SunPower Asset Acquisition
In a strategic move aimed at expanding its foothold in the solar energy sector, Complete Solar has successfully raised $40.5 million through a convertible debenture. This financial maneuver is intended to bolster its ongoing bid for certain asset...

Our Most Popular Articles
Business Update

Globalstar Expands Capabilities with Opening of New Satellite Operations Control Center in Covington, Louisiana

Globalstar Emerges as a Strategic Leader in Next-Gen Satellite Operations Despite Market Fluctuations Globalstar Expands Capabilities with New Operations Center Globalstar, Inc. (NASDAQ: GSAT), a pioneering name in next-generation telecommunications and technology, has taken a significant stride towards strengtheni...

Product Service News

Battle Born Launches Smart Lithium Batteries with Exclusive Black Friday Discounts, Shaping the Future of Energy St...

RENO, Nev. Nov. 25, 2024 Dragonfly Energy Holdings Corp (Nasdaq: DFLI), a recognized leader in energy storage and battery technology, is excited to announce the launch of its latest innovation the new Battle Born smart lithium batteries. This release marks a significant step forward in the evolution of battery ...

Management Changes

“Navigating Financial Headwinds: Village Farms International’s Bold Strategy Amid Regulatory Uncertainty”

Village Farms International Inc. (VFF), a notable entity in the cannabis and fresh produce sectors, is charting a complex course through financial challenges and regulatory hurdles as it positions itself for long-term growth. The appointment of Yvonne Trupiano as the Global Chief Human Resources Officer serves as a ...

More News
Management Announcement

Replimune Group Inc Gains FDA Alignment for RP1 Accelerated Approval Pathway, Inspiring 11.54% Share Price Surge in Q3 2024,

Replimune Announces Positive Pre-BLA Meeting with FDA and Confirms BLA Submission On Track for 2H 2024
- Alignment with FDA on accelerated approval pathway for RP1 in anti-PD1 failed melanoma
- Share price increases by 11.54% in Q3 of 2024
- Cumulative net loss of $-220 million with a negative return on ...

Merger and Acquisition

SMC Entertainment Aims to Diversify Portfolio with Letter of Intent to Acquire Bateau Asset Management


Breaking News
SMC Entertainment Enters Letter of Intent to Acquire Boutique Investment Manager, Bateau Asset Management

In a strategic move aimed at enhancing its investment capabilities, SMC Entertainment Inc. a leader in cloud computing and data analytics, has announced that it has entered into ...

Management Changes

Navigating the Cosmos of Finance: Intuitive Machines Reworks Leadership Amidst Financial Challenges,



In a recent press release, Intuitive Machines, Inc. (Nasdaq: LUNR, LUNRW), a prominent space exploration, infrastructure, and services company, unveiled significant leadership appointments set to take effect on September 16, 2024. These developments include the transition of Pete McGrath from Senior Vice P...

Clinical Study

Advancing Psychedelic Medicine Initiation of Phase IIb Clinical Trial of Psilocybin for Adjustment Disorder in ...

Mark J. Andrews, Ph.D. Department of Pharmacology, CSIMarket.com : Psyence Biomed Ltd, a pioneering entity in the domain of psychedelic biotechnology, has announced the initiation of its first trial site in Australia for a landmark Phase IIb study. This study is poised to evaluate the efficacy of nature-derived ...

Merger and Acquisition

Progress Expands Enterprise Software Portfolio with AI-Powered, Document-Centric Collaboration Platform


Introduction
In an era characterized by digital transformation and remote work, the demand for efficient and innovative collaboration tools has never been greater. Progress Software Corporation, a prominent player in the Software & Programming industry, is set to enhance its enterprise software portfolio wi...

Clinical Study

Terns Pharmaceuticals Advancements in Obesity and Oncology Therapeutics with Promising Phase 1 Clinical Results

The landscape of biopharmaceuticals is rapidly evolving, as innovative compounds and methodologies are emerging to address complex health challenges. Terns Pharmaceuticals is making significant strides with two of its key candidates: TERN-601, a once-daily oral GLP-1 receptor agonist for obesity management, and TERN...

Contract

Telesat Partners with Calian for Element Management System Development as Shares Outperform Market

Telesat Corporation has officially entered into a significant agreement with Canadian technology provider Calian Group Ltd. to develop and implement an Element Management System (EMS) for its next-generation Telesat Lightspeed network. This partnership not only emphasizes Telesat s commitment to enhancing its s...

Clinical Study

Breaking New Ground in Pediatric Autoimmune Therapy Cartesian Therapeutics’ Descartes-08 Garners FDA Rar...

Cartesian Therapeutics, a pioneering cellular therapeutics company, has made significant strides in the field of pediatric medicine. Recently, the company announced that it has received the U.S. Food and Drug Administration (FDA) Rare Pediatric Disease Designation (RPDD) for its drug candidate Descartes-08, aimed at...

Clinical Study

Harnessing Synthetic Biology The Promise of TNX-801 Amidst Financial Challenges for Tonix Pharmaceuticals

Tonix Pharmaceuticals Holding Corp has recently presented promising preclinical data for its Mpox vaccine, TNX-801, at the Immunology Symposium at the University of Alberta. This development comes at a time when the company faces significant financial pressures, including a cumulative net loss of $153 million over ...

Clinical Study

for this Acrivon Therapeutics Unveils Robust Clinical Success and Innovative Pipeline at Upcoming Investor Even...

Acrivon Therapeutics Announces Groundbreaking Developments: Positive Phase 2 Data and Promising Pipeline Progress Webcast Investor Event to Highlight Encouraging Clinical Data and Advancements in Predictive Precision Proteomics Acrivon Therapeutics is set to host a virtual investor event on September 14, 2024, at 9...

Clinical Study

Pivotal Advance in Graves Disease Therapy Immunovants Promising Developments and Challenges in Autoimmune Treatment...

Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to improving the lives of individuals with autoimmune diseases, has recently released promising updates on their development programs targeting Graves Disease. Alongside encouraging advancements, challenges in other autoimmune treatment ...

Clinical Study

Azenosertib Pioneering Synergistic Strategies in Cancer Therapy Through Antibody Drug Conjugates

: Zentalis Pharmaceuticals has made significant advancements in cancer treatment methodology through the preclinical evaluation of Azenosertib, a potent drug candidate exhibiting synergistic effects when paired with topoisomerase I (TOP1) inhibitor-based antibody-drug conjugates (ADCs). This article synthesizes find...

Clinical Study

Evaxion Biotech Achieves Milestones with mRNA Gonorrhea Vaccine EVX-B2 and Personalized Cancer Vaccine EVX-01,

COPENHAGEN, Denmark September 9, 2024 Evaxion Biotech A/S, a pioneering clinical-stage TechBio company renowned for its expertise in AI-driven immunology, has announced significant progress in its vaccine development pipeline with the achievement of pre-clinical Proof-of-Concept for its mRNA Gonorrhea vaccine candidate, EVX-B2. This groundbreaking development comes amidst ongoing advancements in the company’s personalized cancer vaccine, EVX-01, which has also demonstrated promising results as per recent trials presented at significant medical conferences. Proof-of-Concept for EVX-B2 Gonorrhea VaccineIn the latest pre-clinical studies, Evaxion has shown that the EVX-B2 mRNA vaccine effectively triggers a targeted immune response capable of eliminating the gonorrhea bacterium. Gonorrhea, caused by the bacterium Neisseria gonorrhoeae, poses a significant public health challenge globally, with rising antibiotic resistance making effective treatments increasingly scarce. The innovative approach taken by Evaxion could not only provide a much-needed preventive measure against gonorrhea but could also represent a broader application of mRNA technology in combating infectious diseases.

Announcement

Master of Modern Logistics Malcolm Wilson to Grace Morgan Stanleys Laguna Conference,

Intriguing Engage: Malcolm Wilson, GXO Chief Executive, to Illuminate Morgan Stanley s Prestigious Laguna Conference GREENWICH, Conn. Sept. 09, 2024 In a manner befitting the luminaries of the Gilded Age, GXO Logistics, Inc. (NYSE: GXO) stands poised to grace the echelons of the grand Morgan Stanley 12th Annual La...

Announcement

Unlocking Potential MoonLake Immunotherapeutics Poised for Growth Through Regulatory Milestones and Capital Markets U...

MoonLake Immunotherapeutics: Bridging Innovation and Capital Markets in Psoriatic Arthritis Treatment In an era where biotechnology and pharmaceuticals are at the forefront of healthcare innovation, MoonLake Immunotherapeutics has become a notable player in the therapeutic landscape, particularly with its promising ...

Merger and Acquisition

Synergy in Motion: Freedom Holdings and TAG Forge New Paths with Reverse Merger,



In an era where consolidation is becoming a hallmark of innovation and competitive strategy, Freedom Holdings and The Awareness Group (TAG) have announced a binding letter of intent (LOI) for a reverse merger that could signal a transformative development in their respective industries. This strategic coll...



Previous News 1. Page 279. Page 280. Page 281. Page .... 328. Page .... 378. Page NEXT 
Previous News


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.